Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya.

Bwana P, Ageng'o J, Mwau M.

PLoS One. 2019 Mar 22;14(3):e0213865. doi: 10.1371/journal.pone.0213865. eCollection 2019.

2.

Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.

Yu F, Adungo F, Konongoi SL, Inoue S, Sang R, Ashur S, Kwallah AO, Uchida L, Buerano CC, Mwau M, Zha Y, Nie Y, Morita K.

Virol J. 2018 Nov 22;15(1):178. doi: 10.1186/s12985-018-1071-y.

3.

Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV.

Bwana P, Ochieng' L, Mwau M.

PLoS One. 2018 Sep 13;13(9):e0202491. doi: 10.1371/journal.pone.0202491. eCollection 2018.

4.

Leishmaniasis recidivans by Leishmania tropica in Central Rift Valley Region in Kenya.

Gitari JW, Nzou SM, Wamunyokoli F, Kinyeru E, Fujii Y, Kaneko S, Mwau M.

Int J Infect Dis. 2018 Sep;74:109-116. doi: 10.1016/j.ijid.2018.07.008. Epub 2018 Jul 11.

5.

Health worker knowledge of Integrated Disease Surveillance and Response standard case definitions: a cross-sectional survey at rural health facilities in Kenya.

Toda M, Zurovac D, Njeru I, Kareko D, Mwau M, Morita K.

BMC Public Health. 2018 Jan 17;18(1):146. doi: 10.1186/s12889-018-5028-2.

6.

Scale-up of Kenya's national HIV viral load program: Findings and lessons learned.

Mwau M, Syeunda CA, Adhiambo M, Bwana P, Kithinji L, Mwende J, Oyiengo L, Sirengo M, Boeke CE.

PLoS One. 2018 Jan 11;13(1):e0190659. doi: 10.1371/journal.pone.0190659. eCollection 2018.

7.

"It takes more than a fellowship program": reflections on capacity strengthening for health systems research in sub-Saharan Africa.

Izugbara CO, Kabiru CW, Amendah D, Dimbuene ZT, Donfouet HPP, Atake EH, Ingabire MG, Maluka S, Mumah JN, Mwau M, Ndinya M, Ngure K, Sidze EM, Sossa C, Soura A, Ezeh AC.

BMC Health Serv Res. 2017 Dec 4;17(Suppl 2):696. doi: 10.1186/s12913-017-2638-9.

8.

Experience from a pilot point-of-care CD4 enumeration programme in Kenya.

Mwau M, Umuro M, Odhiambo CO.

Afr J Lab Med. 2016 Oct 17;5(2):439. doi: 10.4102/ajlm.v5i2.439. eCollection 2016. No abstract available.

9.

Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.

Mwau M, Bwana P, Kithinji L, Ogollah F, Ochieng S, Akinyi C, Adhiambo M, Ogumbo F, Sirengo M, Boeke C.

PLoS One. 2017 Aug 29;12(8):e0183860. doi: 10.1371/journal.pone.0183860. eCollection 2017.

10.

Understanding mSOS: A qualitative study examining the implementation of a text-messaging outbreak alert system in rural Kenya.

Toda M, Njeru I, Zurovac D, Kareko D, O-Tipo S, Mwau M, Morita K.

PLoS One. 2017 Jun 19;12(6):e0179408. doi: 10.1371/journal.pone.0179408. eCollection 2017.

11.

Correction: The BD FACSPresto Point of Care CD4 Test accurately enumerates CD4+ T cell counts.

Bwana P, Vojnov L, Adhiambo M, Akinyi C, Mwende J, Prescott M, Mwau M.

PLoS One. 2016 Dec 9;11(12):e0167667. doi: 10.1371/journal.pone.0167667. eCollection 2016.

12.

An in vitro evaluation of drugs used in the Kenyan ART program.

Muriuki J, Ng'ang'a Z, Lihana R, Lwembe R, Mwangi J, Mwau M.

Pan Afr Med J. 2016 Mar 25;23:134. doi: 10.11604/pamj.2016.23.134.7157. eCollection 2016.

13.

Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.

Adungo F, Yu F, Kamau D, Inoue S, Hayasaka D, Posadas-Herrera G, Sang R, Mwau M, Morita K.

Clin Vaccine Immunol. 2016 Aug 5;23(8):689-97. doi: 10.1128/CVI.00209-16. Print 2016 Aug.

14.

Effectiveness of a Mobile Short-Message-Service-Based Disease Outbreak Alert System in Kenya.

Toda M, Njeru I, Zurovac D, O-Tipo S, Kareko D, Mwau M, Morita K.

Emerg Infect Dis. 2016 Apr;22(4):711-5. doi: 10.3201/eid2204.151459. Erratum in: Emerg Infect Dis. 2016 Aug;22(8):1523.

15.

Spatial Distributions of HIV Infection in an Endemic Area of Western Kenya: Guiding Information for Localized HIV Control and Prevention.

Hoshi T, Fuji Y, Nzou SM, Tanigawa C, Kiche I, Mwau M, Mwangi AW, Karama M, Hirayama K, Goto K, Kaneko S.

PLoS One. 2016 Feb 10;11(2):e0148636. doi: 10.1371/journal.pone.0148636. eCollection 2016.

16.

The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts.

Bwana P, Vojnov L, Adhiambo M, Akinyi C, Mwende J, Prescott M, Mwau M.

PLoS One. 2015 Dec 31;10(12):e0145586. doi: 10.1371/journal.pone.0145586. eCollection 2015. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0167667.

17.

Development of multiplex serological assay for the detection of human African trypanosomiasis.

Nzou SM, Fujii Y, Miura M, Mwau M, Mwangi AW, Itoh M, Salam MA, Hamano S, Hirayama K, Kaneko S.

Parasitol Int. 2016 Apr;65(2):121-7. doi: 10.1016/j.parint.2015.10.008. Epub 2015 Nov 10.

18.

Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay.

Tanigawa C, Fujii Y, Miura M, Nzou SM, Mwangi AW, Nagi S, Hamano S, Njenga SM, Mbanefo EC, Hirayama K, Mwau M, Kaneko S.

PLoS Negl Trop Dis. 2015 Aug 20;9(8):e0004021. doi: 10.1371/journal.pntd.0004021. eCollection 2015.

19.

Correction: Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.

Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Ziraba A, Mwau M.

PLoS One. 2015 Jul 20;10(7):e0133342. doi: 10.1371/journal.pone.0133342. eCollection 2015. No abstract available.

20.

Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.

Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Ziraba A, Mwau M.

PLoS One. 2015 Jun 12;10(6):e0129247. doi: 10.1371/journal.pone.0129247. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0133342. Abdalla, Ziraba [correctd to Ziraba, Abdhalah].

21.

Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.

Kwallah Ao, Inoue S, Thairu-Muigai AW, Kuttoh N, Morita K, Mwau M.

Jpn J Infect Dis. 2015;68(3):230-4. doi: 10.7883/yoken.JJID.2014.288. Epub 2014 Dec 24.

22.

Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration.

Mwau M, Kadima S, Mwende J, Adhiambo M, Akinyi C, Prescott M, Lusike J, Hungu J, Vojnov L.

PLoS One. 2014 Sep 17;9(9):e107410. doi: 10.1371/journal.pone.0107410. eCollection 2014.

23.

Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models.

Fujii Y, Kaneko S, Nzou SM, Mwau M, Njenga SM, Tanigawa C, Kimotho J, Mwangi AW, Kiche I, Matsumoto S, Niki M, Osada-Oka M, Ichinose Y, Inoue M, Itoh M, Tachibana H, Ishii K, Tsuboi T, Yoshida LM, Mondal D, Haque R, Hamano S, Changoma M, Hoshi T, Kamo K, Karama M, Miura M, Hirayama K.

PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3040. doi: 10.1371/journal.pntd.0003040. eCollection 2014.

24.

Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Mwau M, Adungo F, Kadima S, Njagi E, Kirwaye C, Abubakr NS, Okubi LA, Waihenya M, Lusike J, Hungu J.

PLoS One. 2013 Jun 25;8(6):e67612. doi: 10.1371/journal.pone.0067612. Print 2013.

25.

A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus.

Kwallah Ao, Inoue S, Muigai AW, Kubo T, Sang R, Morita K, Mwau M.

J Virol Methods. 2013 Oct;193(1):23-7. doi: 10.1016/j.jviromet.2013.05.004. Epub 2013 May 18.

PMID:
23692685
26.

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.

Ferreyra C, Yun O, Eisenberg N, Alonso E, Khamadi AS, Mwau M, Mugendi MK, Alvarez A, Velilla E, Flevaud L, Arnedo M, Dalmau D, Roddy P, Bernasconi A, Palma PP.

PLoS One. 2012;7(11):e49834. doi: 10.1371/journal.pone.0049834. Epub 2012 Nov 21.

27.

Are slum dwellers at heightened risk of HIV infection than other urban residents? Evidence from population-based HIV prevalence surveys in Kenya.

Madise NJ, Ziraba AK, Inungu J, Khamadi SA, Ezeh A, Zulu EM, Kebaso J, Okoth V, Mwau M.

Health Place. 2012 Sep;18(5):1144-52. doi: 10.1016/j.healthplace.2012.04.003. Epub 2012 Apr 26.

28.

Early detection of HIV infection among Kenyan infants using a reverse transcriptase activity assay.

Sivapalasingam S, Ahmed A, Mendillo M, Holzman R, Marshed F, Mwamzuka M, Khamadi S, Mwau M, Laverty M, Valentine F.

Pediatr Infect Dis J. 2012 Jul;31(7):732-5. doi: 10.1097/INF.0b013e318259bc1e.

29.

Discrepant test findings in early infant diagnosis of HIV in a national reference laboratory in Kenya: challenges and opportunities for programs.

Kageha S, Okoth V, Kadima S, Vihenda S, Okapesi E, Nyambura E, Maiyo A, Ndung'u N, Khamadi S, Mwau M.

J Trop Pediatr. 2012 Aug;58(4):247-52. doi: 10.1093/tropej/fmr076. Epub 2011 Nov 3.

PMID:
22052701
30.

HIV type 1 subtype surveillance in central Kenya.

Kageha S, Lihana RW, Okoth V, Mwau M, Okoth FA, Songok EM, Ngaira JM, Khamadi SA.

AIDS Res Hum Retroviruses. 2012 Feb;28(2):228-31. doi: 10.1089/aid.2011.0089. Epub 2011 Jul 8.

PMID:
21740274
31.

Genetic diversity of HIV type 1 along the coastal strip of Kenya.

Khamadi SA, Lihana RW, Osman S, Mwangi J, Muriuki J, Lagat N, Kinyua J, Mwau M, Kageha S, Okoth V, Ochieng W, Okoth FA.

AIDS Res Hum Retroviruses. 2009 Sep;25(9):919-23. doi: 10.1089/aid.2009.0005.

PMID:
19751145
32.

Molecular genetic diversity of hepatitis B virus in Kenya.

Mwangi J, Nganga Z, Songok E, Kinyua J, Lagat N, Muriuki J, Lihana R, Khamadi S, Osman S, Lwembe R, Kiptoo M, Mwau M, Chirchir R, Mpoke S, Nyamongo J, Okoth F, Yamada R, Kageyama S, Ichimura H.

Intervirology. 2008;51(6):417-21. doi: 10.1159/000205526. Epub 2009 Mar 4.

PMID:
19258721
33.

Rapid identification of infants for antiretroviral therapy in a resource poor setting: the Kenya experience.

Khamadi S, Okoth V, Lihana R, Nabwera J, Hungu J, Okoth F, Lubano K, Mwau M.

J Trop Pediatr. 2008 Dec;54(6):370-4. doi: 10.1093/tropej/fmn036. Epub 2008 May 29.

PMID:
18511477
34.

HIV type 1 subtypes among STI patients in Nairobi: a genotypic study based on partial pol gene sequencing.

Lihana RW, Khamadi SA, Kiptoo MK, Kinyua JG, Lagat N, Magoma GN, Mwau MM, Makokha EP, Onyango V, Osman S, Okoth FA, Songok EM.

AIDS Res Hum Retroviruses. 2006 Nov;22(11):1172-7.

PMID:
17147506
35.

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

Mwau M, Cebere I, Sutton J, Chikoti P, Winstone N, Wee EG, Beattie T, Chen YH, Dorrell L, McShane H, Schmidt C, Brooks M, Patel S, Roberts J, Conlon C, Rowland-Jones SL, Bwayo JJ, McMichael AJ, Hanke T.

J Gen Virol. 2004 Apr;85(Pt 4):911-9.

PMID:
15039533
36.

A review of vaccines for HIV prevention.

Mwau M, McMichael AJ.

J Gene Med. 2003 Jan;5(1):3-10. Review.

PMID:
12516046
37.

Design and tests of an HIV vaccine.

McMichael A, Mwau M, Hanke T.

Br Med Bull. 2002;62:87-98. Review.

PMID:
12176852
38.

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines.

Mwau M, McMichael AJ, Hanke T.

AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):611-8.

PMID:
12079556
39.

Development of a DNA-MVA/HIVA vaccine for Kenya.

Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV.

Vaccine. 2002 May 6;20(15):1995-8. Review.

PMID:
11983261
40.

HIV T cell vaccines, the importance of clades.

McMichael A, Mwau M, Hanke T.

Vaccine. 2002 May 6;20(15):1918-21. Review.

PMID:
11983245

Supplemental Content

Support Center